Proto Labs Inc (PRLB) financial statements: income statement, balance sheet and cash flow
Proto Labs Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Proto Labs Inc reported revenue of $533.1M (+6.4% year on year) and net income of $21.2M (+28.0% year on year).
Income statement
Proto Labs Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenue
$533.1M
$500.9M
$503.9M
$488.4M
Cost of revenue
$296.0M
$277.7M
$281.9M
$272.9M
Gross profit
$237.1M
$223.2M
$222.0M
$215.5M
Marketing and sales
$98.3M
$92.1M
$87.7M
$82.8M
Research and development
$42.8M
$41.3M
$40.1M
$38.2M
General and administrative
$69.8M
$64.3M
$65.8M
$67.5M
Restructuring and transformation costs
$749.0K
—
—
—
Costs related to disposal and exit activities
$342.0K
$5.6M
—
—
Total operating expenses
$212.0M
$203.3M
$193.8M
$313.4M
Income from operations
$25.1M
$19.9M
$28.2M
($98.0M)
Other income (expense), net
$6.0M
$4.8M
($215.0K)
$106.0K
Income before income taxes
$31.1M
$24.7M
$28.0M
($97.9M)
Provision for income taxes
$9.8M
$8.1M
$10.7M
$5.6M
Net income
$21.2M
$16.6M
$17.2M
($103.5M)
Basic (in dollars per share)
$0.89
$0.66
$0.66
-$3.77
Diluted (in dollars per share)
$0.88
$0.66
$0.66
-$3.77
Basic (in shares)
23.9M
25.1M
26.2M
27.4M
Diluted (in shares)
24.2M
25.2M
26.2M
27.4M
Foreign currency translation adjustments
$6.8M
($228.0K)
$5.4M
($16.3M)
Net unrealized gains on investments in securities
$195.0K
$257.0K
$977.0K
($1.3M)
Comprehensive income
$28.2M
$16.6M
$23.6M
($121.0M)
Proto Labs Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenue
$149.3M
$139.3M
$135.4M
$135.1M
Cost of revenue
$80.0M
$75.7M
$74.1M
$75.3M
Gross profit
$69.3M
$63.6M
$61.3M
$59.8M
Marketing and sales
$25.7M
$24.8M
$24.6M
$24.7M
Research and development
$10.8M
$10.5M
$10.7M
$11.2M
General and administrative
$19.6M
$17.0M
$17.2M
$18.8M
Restructuring and transformation costs
$924.0K
$1.4M
—
—
Costs related to exit and disposal activities
$937.0K
$0
$41.0K
$149.0K
Total operating expenses
$58.0M
$53.8M
$52.5M
$54.8M
Income from operations
$11.4M
$9.8M
$8.8M
$5.0M
Other income, net
$1.2M
$1.5M
$1.4M
$1.7M
Income before income taxes
$12.6M
$11.3M
$10.3M
$6.7M
Provision for income taxes
$3.5M
$3.2M
$3.0M
$2.2M
Net income
$9.2M
$8.1M
$7.2M
$4.4M
Basic (in dollars per share)
$0.38
$0.34
$0.30
$0.19
Diluted (in dollars per share)
$0.37
$0.33
$0.30
$0.18
Basic (in shares)
24.0M
23.8M
23.9M
23.9M
Diluted (in shares)
24.4M
24.3M
24.2M
24.1M
Comprehensive income
$9.4M
$5.6M
$7.1M
$6.8M
Balance sheet
Proto Labs Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$110.8M
$89.1M
$83.8M
$56.6M
Short-term marketable securities
$17.3M
$14.0M
$19.0M
$23.6M
Accounts receivable, net of allowance for credit losses of $2,668 and $1,975 as of December 31, 2025 and December 31, 2024, respectively
$79.0M
$66.5M
$72.8M
$76.2M
Inventory
$14.4M
$12.3M
$13.7M
$13.6M
Prepaid expenses and other current assets
$9.6M
$10.0M
$9.1M
$12.6M
Income taxes receivable
$2.5M
$2.9M
$2.2M
$4.0M
Total current assets
$233.5M
$194.9M
$200.7M
$186.6M
Property and equipment, net
$215.3M
$227.3M
$253.7M
$257.8M
Goodwill
$274.0M
$274.0M
$274.0M
$274.0M
Other intangible assets, net
$18.6M
$21.4M
$25.6M
$31.3M
Long-term marketable securities
$14.3M
$17.8M
$8.0M
$26.4M
Operating lease assets
$2.8M
$3.0M
$4.6M
$3.8M
Finance lease assets
$424.0K
$692.0K
$960.0K
$17.5M
Other long-term assets
$4.4M
$4.5M
$4.9M
$4.8M
Total assets
$763.4M
$743.5M
$772.4M
$802.2M
Accounts payable
$15.1M
$15.5M
$15.6M
$17.4M
Accrued compensation
$23.7M
$16.6M
$15.3M
$12.7M
Accrued liabilities and other
$26.8M
$19.6M
$16.9M
$22.4M
Current operating lease liabilities
$1.2M
$1.3M
$1.6M
$1.6M
Current finance lease liabilities
$286.0K
$309.0K
$296.0K
$17.5M
Total current liabilities
$67.0M
$53.3M
$49.7M
$71.6M
Long-term operating lease liabilities
$1.6M
$1.6M
$3.0M
$2.3M
Long-term finance lease liabilities
$0
$287.0K
$595.0K
$0
Long-term deferred tax liabilities
$16.6M
$13.6M
$18.7M
$26.3M
Other long-term liabilities
$4.3M
$4.6M
$5.0M
$4.4M
Total liabilities
$89.5M
$73.4M
$77.1M
$104.5M
Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of December 31, 2025 and December 31, 2024, respectively
0
0
0
0
Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 23,627,422 and 24,226,088 shares as of December 31, 2025 and December 31, 2024, respectively
24.0K
24.0K
26.0K
27.0K
Additional paid-in capital
$454.1M
$453.7M
$466.9M
$473.7M
Retained earnings
$240.8M
$244.4M
$256.4M
$258.2M
Accumulated other comprehensive loss
($21.0M)
($28.0M)
($28.0M)
($34.4M)
Total shareholders' equity
$673.9M
$670.2M
$695.3M
$697.6M
Total liabilities and shareholders' equity
$763.4M
$743.5M
$772.4M
$802.2M
Proto Labs Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$127.9M
$124.0M
$104.4M
$90.4M
Short-term marketable securities
$14.9M
$12.3M
$14.8M
$12.8M
Accounts receivable, net of allowance for credit losses of $3,022 and $2,668 as of June 30, 2026, and December 31, 2025, respectively
$95.1M
$85.6M
$77.8M
$78.0M
Inventory
$15.4M
$14.9M
$14.1M
$13.2M
Prepaid expenses and other current assets
$11.6M
$10.7M
$10.0M
$10.0M
Income taxes receivable
$1.4M
$1.2M
$4.7M
$1.2M
Total current assets
$266.2M
$248.6M
$225.8M
$205.5M
Property and equipment, net
$208.3M
$209.5M
$211.3M
$215.8M
Goodwill
$274.0M
$274.0M
$274.0M
$274.0M
Other intangible assets, net
$16.6M
$17.5M
$19.5M
$20.5M
Long-term marketable securities
$20.1M
$21.7M
$19.1M
$20.0M
Operating lease assets
$1.3M
$2.5M
$2.0M
$2.3M
Finance lease assets
$290.0K
$357.0K
$491.0K
$558.0K
Other long-term assets
$4.5M
$4.4M
$4.6M
$4.6M
Total assets
$791.3M
$778.6M
$756.9M
$743.3M
Accounts payable
$21.5M
$19.6M
$17.4M
$15.6M
Accrued compensation
$18.8M
$17.3M
$23.3M
$19.4M
Accrued liabilities and other
$31.8M
$32.6M
$27.8M
$25.8M
Current operating lease liabilities
$929.0K
$1.0M
$890.0K
$984.0K
Current finance lease liabilities
$127.0K
$207.0K
$365.0K
$316.0K
Total current liabilities
$73.2M
$70.7M
$69.7M
$62.2M
Long-term operating lease liabilities
$1.2M
$1.4M
$1.2M
$1.4M
Long-term deferred tax liabilities
$20.6M
$18.9M
$16.0M
$9.7M
Other long-term liabilities
$4.6M
$4.4M
$5.2M
$5.1M
Total liabilities
$99.6M
$95.4M
$92.1M
$78.5M
Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of June 30, 2026, and December 31, 2025, respectively
0
0
0
0
Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 23,921,897 and 23,627,422 shares as of June 30, 2026, and December 31, 2025, respectively
24.0K
24.0K
23.0K
23.0K
Additional paid-in capital
$460.7M
$457.7M
$450.9M
$449.9M
Retained earnings
$254.3M
$248.9M
$238.6M
$239.3M
Accumulated other comprehensive loss
($23.3M)
($23.5M)
($24.7M)
($24.6M)
Total shareholders' equity
$691.7M
$683.1M
$664.7M
$664.7M
Total liabilities and shareholders' equity
$791.3M
$778.6M
$756.9M
$743.3M
Cash flow statement
Proto Labs Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$21.2M
$16.6M
$17.2M
($103.5M)
Depreciation and amortization
$33.8M
$35.8M
$37.5M
$39.4M
Stock-based compensation expense
$15.7M
$17.0M
$16.0M
$17.5M
Deferred taxes
$2.9M
($5.2M)
($7.7M)
($9.5M)
Interest on finance lease obligations
$20.0K
$33.0K
$1.1M
—
Loss on foreign currency translation
$0
$0
$3.9M
—
Loss on impairment of equipment
$0
$256.0K
—
—
Impairments related to exit and closure of Germany business
$448.0K
$2.3M
$0
$2.8M
Gain on disposal of property and equipment
($4.0K)
($13.0K)
($498.0K)
($1.2M)
Other
($223.0K)
$1.0K
$154.0K
$35.0K
Accounts receivable
($12.5M)
$9.7M
$2.7M
$1.6M
Inventories
($2.1M)
$1.3M
$112.0K
($310.0K)
Prepaid expenses and other
$1.0M
($560.0K)
$4.2M
($2.1M)
Income taxes
$508.0K
($691.0K)
$1.8M
($2.7M)
Accounts payable
($333.0K)
$480.0K
($1.8M)
$1.4M
Accrued liabilities and other
$14.0M
$835.0K
($1.5M)
$461.0K
Net cash provided by operating activities
$74.5M
$77.8M
$73.3M
$62.1M
Purchases of property, equipment and other capital assets
($14.8M)
($9.2M)
($28.1M)
($21.7M)
Proceeds from sales of property, equipment and other capital assets
$834.0K
$34.0K
$699.0K
$4.1M
Purchases of other assets and investments
$0
$0
($1.0M)
$0
Purchases of marketable securities
($17.0M)
($25.1M)
$0
($46.9M)
Proceeds from sales of marketable securities
$0
$1.4M
$0
$2.0M
Proceeds from maturities of marketable securities
$17.6M
$19.2M
$23.9M
$19.4M
Net cash used in investing activities
($13.4M)
($13.6M)
($4.6M)
($43.1M)
Proceeds from issuance of common stock from equity plans
6.3M
4.0M
3.8M
4.0M
Purchases of shares withheld for tax obligations
-3.4M
-2.0M
-1.4M
-1.7M
Repurchases of common stock and other
($43.0M)
($60.3M)
($44.0M)
($29.7M)
Principal repayments of finance lease obligations
($309.0K)
($296.0K)
($306.0K)
($531.0K)
Net cash used in financing activities
($40.4M)
($58.5M)
($41.9M)
($27.9M)
Effect of exchange rate changes on cash and cash equivalents
$1.0M
($418.0K)
$368.0K
($436.0K)
Net increase (decrease) in cash and cash equivalents
$21.8M
$5.3M
$27.2M
($9.4M)
Cash and cash equivalents, beginning of period
$89.1M
$83.8M
$56.6M
$65.9M
Cash and cash equivalents, end of period
$110.8M
$89.1M
$83.8M
$56.6M
Cash paid for interest
$58.0K
$136.0K
$1.1M
$101.0K
Cash paid for taxes
$6.7M
$13.9M
$15.9M
$19.2M
Proto Labs Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$17.3M
$8.1M
$15.2M
$8.0M
Depreciation and amortization
$16.2M
$8.1M
$25.7M
$17.3M
Stock-based compensation expense
$7.3M
$3.2M
$11.9M
$8.3M
Deferred taxes
$4.1M
$2.4M
$2.4M
($4.0M)
Interest on finance lease obligations
$5.0K
$3.0K
$16.0K
$11.0K
Loss on impairment of equipment
$186.0K
—
$0
—
Impairments related to exit and closure of facilities
$937.0K
$0
$448.0K
$448.0K
Gain on disposal of property and equipment
($120.0K)
($139.0K)
$16.0K
$0
Other
($152.0K)
($172.0K)
($179.0K)
($82.0K)
Accounts receivable
($16.4M)
($6.9M)
($11.3M)
($9.5M)
Inventories
($1.1M)
($585.0K)
($2.0M)
($983.0K)
Prepaid expenses and other
($2.1M)
($1.2M)
$366.0K
$338.0K
Income taxes
$1.1M
$1.3M
($1.7M)
$1.8M
Accounts payable
$5.9M
$3.9M
$1.3M
($654.0K)
Accrued liabilities and other
$5.0K
($551.0K)
$15.9M
$8.0M
Net cash provided by operating activities
$33.0M
$17.5M
$58.1M
$29.0M
Purchases of property, equipment and other capital assets
($9.7M)
($3.5M)
($6.8M)
($2.7M)
Proceeds from sales of property, equipment and other capital assets
$1.3M
$1.3M
$811.0K
$0
Purchases of marketable securities
($16.0M)
($9.0M)
($13.6M)
($11.1M)
Proceeds from maturities of marketable securities
$12.5M
$6.5M
$11.7M
$10.2M
Net cash used in investing activities
($12.0M)
($4.8M)
($7.8M)
($3.6M)
Proceeds from issuance of common stock from equity plans
7.3M
3.6M
4.2M
2.1M
Purchases of shares withheld for tax obligations
-6.0M
-2.9M
-3.1M
-3.1M
Repurchases of common stock
($5.0M)
$0
($36.7M)
($24.0M)
Principal repayments of finance lease obligations
($160.0K)
($79.0K)
($231.0K)
($153.0K)
Net cash used in financing activities
($3.9M)
$658.0K
($35.9M)
($25.2M)
Effect of exchange rate changes on cash and cash equivalents